EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Inhalable Dry Powders for Lung mRNA Delivery

Akiva Gordon iD, Bowen Li, Jacob Witten iD, Hong Nguyen, Daniel G Anderson iD

Advanced Healthcare Materials · 2024-11 · 13 (29)

DOI: 10.1002/adhm.202400509 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 01.10.2024. Verfasst von Akiva Gordon und 4 weiteren Autor:innen. Beteiligte Einrichtung: David H Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA. Hauptthemen laut MEDLINE: Powders, Lung, RNA, Messenger. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cystic Fibrosis Foundation, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite great promise, application of mRNA therapeutics in the lung has proven challenging. Many groups have reported success instilling liquid mRNA formulations in animal models, but direct intratracheal administration of large liquid quantities to the human lung presents significant safety and distribution concerns. To accomplish safe and effective mRNA delivery to the lung, formulations must be prepared for dosing via inhalation. An inhaled mRNA delivery system for the lung must be both robust enough to survive inhalation conditions and potent enough to deliver mRNA upon reaching the lung. In this work dry powder lipid nanoparticle formulations are developed, using spray‐freeze‐drying, to produce stable, biologically active, inhalable dry powders for mRNA delivery. The final powders have suitable aerosolization properties, with mean mass aerodynamic diameter (MMAD) of 3–4 microns, and fine particle fraction (FPF) ≈40%, allowing for efficient mRNA delivery to the deep lung following inhalation. Importantly, the formulations developed here are suitable for use with different ionizable lipids. Four different ionizable lipid‐based formulations are evaluated as powders, and all exhibit in vivo pulmonary mRNA delivery equal to that of instilled liquid formulations. These results lay promising groundwork for the eventual development of an inhalable mRNA dry powder therapeutic.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PowdersLungRNA, MessengerAdministration, InhalationAnimalsNanoparticlesParticle SizeAerosolsDry Powder InhalersHumansLipidsMice

Stichwörter der Autor:innen

dry powderlipid nanoparticlesmRNA deliverypulmonary delivery

Substanzen

PowdersRNA, MessengerAerosolsLipids

Autor:innen und Institutionen

  • David H Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.
  • Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.
  • Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada.
  • Institute of Biomedical Engineering, University of Toronto, Toronto, Ontario, Canada.
  • Department of Chemistry, University of Toronto, Toronto, Ontario, Canada.
  • Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.

ORCID-Profile: Akiva Gordon, Jacob Witten, Daniel G Anderson

Förderung

  • Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
  • Cystic Fibrosis Foundation
  • NIAID NIH HHS
  • Alpha-1 Foundation
  • NIH HHS
  • Sanofi
  • NHLBI NIH HHS
  • NCI NIH HHS

Zitieren

APA

Gordon, A., Li, B., Witten, J., Nguyen, H., & Anderson, D. G. (2024). Inhalable Dry Powders for Lung mRNA Delivery. Advanced Healthcare Materials, 13(29). https://doi.org/10.1002/adhm.202400509

Vancouver

Gordon A, Li B, Witten J, Nguyen H, Anderson DG. Inhalable Dry Powders for Lung mRNA Delivery. Advanced Healthcare Materials. 2024;13(29). doi:10.1002/adhm.202400509

BibTeX
@article{Gordon2024,
  author = {Gordon, Akiva and Li, Bowen and Witten, Jacob and Nguyen, Hong and Anderson, Daniel G},
  title = {Inhalable Dry Powders for Lung mRNA Delivery},
  journal = {Advanced Healthcare Materials},
  year = {2024},
  volume = {13},
  number = {29},
  doi = {10.1002/adhm.202400509}
}
Kostenlos starten →